Cargando…

Особенности применения синтетических аналогов гормонов щитовидной железы: результаты международного исследования 2020 THESIS* среди членов Белорусского общественного медицинского объединения «Эндокринология и метаболизм»

BACKGROUND: BACKGROUND. The standard treatment for hypothyroidism is levothyroxine (LT4), which in the Republic of Belarus is available in tablet form whereas liothyronine (LT3) is not registered, but patients can purchase them on their own abroad. AIM: AIM. This study aimed to investigate Belarusia...

Descripción completa

Detalles Bibliográficos
Autores principales: Шепелькевич, А. П., Дыдышко, Ю. В., Юреня, Е. B., Лобашова, В. Л., Аттанасио, Р., Хегедюс, Л., Надь, Э., Негро, Р., Папини, Э., Перрос, П.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrinology Research Centre 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112860/
https://www.ncbi.nlm.nih.gov/pubmed/35262294
http://dx.doi.org/10.14341/probl12828
_version_ 1784709489266524160
author Шепелькевич, А. П.
Дыдышко, Ю. В.
Юреня, Е. B.
Лобашова, В. Л.
Аттанасио, Р.
Хегедюс, Л.
Надь, Э.
Негро, Р.
Папини, Э.
Перрос, П.
author_facet Шепелькевич, А. П.
Дыдышко, Ю. В.
Юреня, Е. B.
Лобашова, В. Л.
Аттанасио, Р.
Хегедюс, Л.
Надь, Э.
Негро, Р.
Папини, Э.
Перрос, П.
author_sort Шепелькевич, А. П.
collection PubMed
description BACKGROUND: BACKGROUND. The standard treatment for hypothyroidism is levothyroxine (LT4), which in the Republic of Belarus is available in tablet form whereas liothyronine (LT3) is not registered, but patients can purchase them on their own abroad. AIM: AIM. This study aimed to investigate Belarusian endocrinologists’ attitude of thyroid hormones in hypothyroid and euthyroid patients. MATERIALS AND METHODS: MATERIALS AND METHODS. An online survey was conducted, for which members of the Belarusian Medical Association of Endocrinology and Metabolism were invited by posting information in the group chat and by e-mail. The research period was from October 1 to December 26, 2020. 210 questionnaires were received, 146 of which were used. RESULTS: RESULTS. The majority of participants, 145 (99.3%), indicated that they were using LT4 as the first-choice drug for the treatment hypothyroidism. Sixty-one (41.8%) doctors answered that LT3 + LT4 combination likely can be used in patients with long-term untreated hypothyroidism and 15 (10.3%) — in patients with persistent symptoms of hypothyroidism, despite biochemical euthyroidism on therapy LT4. Over half of the respondents 84 (57.5%) answered that thyroid hormone therapy was never indicated for euthyroid patients, but 50 (34.2%) would consider it for female infertility with high level of thyroid antibodies and 36 (24.7%) for simple goiter growing over time. In various conditions that could interfere with absorption of LT4, most responding Belarusian endocrinologists do not expect a significant difference with different formulations (tablets +“I do not expect major changes in different forms” vs. “soft gel capsules”+“liquid solution”; p <0.001). Persistent symptoms of hypothyroidism on the background of LT4 replacement therapy with the achievement of the target TSH can mainly be caused by psychosocial factors, concomitant diseases, unrealistic patient expectations, chronic fatigue syndrome, and the burden of chronic disease. CONCLUSION: CONCLUSION. The method of choice of Belarusian endocrinologists in the treatment of hypothyroidism is LT4 replacement therapy, but the appointment of LT4 + LT3 combination therapy can be considered in certain clinical situations. As a rule, endocrinologists do not prescribe LT4 in patients with euthyroidism and do not expect a significant difference when using other forms of levothyroxine.
format Online
Article
Text
id pubmed-9112860
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Endocrinology Research Centre
record_format MEDLINE/PubMed
spelling pubmed-91128602022-12-14 Особенности применения синтетических аналогов гормонов щитовидной железы: результаты международного исследования 2020 THESIS* среди членов Белорусского общественного медицинского объединения «Эндокринология и метаболизм» Шепелькевич, А. П. Дыдышко, Ю. В. Юреня, Е. B. Лобашова, В. Л. Аттанасио, Р. Хегедюс, Л. Надь, Э. Негро, Р. Папини, Э. Перрос, П. Probl Endokrinol (Mosk) Research Article BACKGROUND: BACKGROUND. The standard treatment for hypothyroidism is levothyroxine (LT4), which in the Republic of Belarus is available in tablet form whereas liothyronine (LT3) is not registered, but patients can purchase them on their own abroad. AIM: AIM. This study aimed to investigate Belarusian endocrinologists’ attitude of thyroid hormones in hypothyroid and euthyroid patients. MATERIALS AND METHODS: MATERIALS AND METHODS. An online survey was conducted, for which members of the Belarusian Medical Association of Endocrinology and Metabolism were invited by posting information in the group chat and by e-mail. The research period was from October 1 to December 26, 2020. 210 questionnaires were received, 146 of which were used. RESULTS: RESULTS. The majority of participants, 145 (99.3%), indicated that they were using LT4 as the first-choice drug for the treatment hypothyroidism. Sixty-one (41.8%) doctors answered that LT3 + LT4 combination likely can be used in patients with long-term untreated hypothyroidism and 15 (10.3%) — in patients with persistent symptoms of hypothyroidism, despite biochemical euthyroidism on therapy LT4. Over half of the respondents 84 (57.5%) answered that thyroid hormone therapy was never indicated for euthyroid patients, but 50 (34.2%) would consider it for female infertility with high level of thyroid antibodies and 36 (24.7%) for simple goiter growing over time. In various conditions that could interfere with absorption of LT4, most responding Belarusian endocrinologists do not expect a significant difference with different formulations (tablets +“I do not expect major changes in different forms” vs. “soft gel capsules”+“liquid solution”; p <0.001). Persistent symptoms of hypothyroidism on the background of LT4 replacement therapy with the achievement of the target TSH can mainly be caused by psychosocial factors, concomitant diseases, unrealistic patient expectations, chronic fatigue syndrome, and the burden of chronic disease. CONCLUSION: CONCLUSION. The method of choice of Belarusian endocrinologists in the treatment of hypothyroidism is LT4 replacement therapy, but the appointment of LT4 + LT3 combination therapy can be considered in certain clinical situations. As a rule, endocrinologists do not prescribe LT4 in patients with euthyroidism and do not expect a significant difference when using other forms of levothyroxine. Endocrinology Research Centre 2021-12-06 /pmc/articles/PMC9112860/ /pubmed/35262294 http://dx.doi.org/10.14341/probl12828 Text en Copyright © Endocrinology Research Centre, 2022 https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 License.
spellingShingle Research Article
Шепелькевич, А. П.
Дыдышко, Ю. В.
Юреня, Е. B.
Лобашова, В. Л.
Аттанасио, Р.
Хегедюс, Л.
Надь, Э.
Негро, Р.
Папини, Э.
Перрос, П.
Особенности применения синтетических аналогов гормонов щитовидной железы: результаты международного исследования 2020 THESIS* среди членов Белорусского общественного медицинского объединения «Эндокринология и метаболизм»
title Особенности применения синтетических аналогов гормонов щитовидной железы: результаты международного исследования 2020 THESIS* среди членов Белорусского общественного медицинского объединения «Эндокринология и метаболизм»
title_full Особенности применения синтетических аналогов гормонов щитовидной железы: результаты международного исследования 2020 THESIS* среди членов Белорусского общественного медицинского объединения «Эндокринология и метаболизм»
title_fullStr Особенности применения синтетических аналогов гормонов щитовидной железы: результаты международного исследования 2020 THESIS* среди членов Белорусского общественного медицинского объединения «Эндокринология и метаболизм»
title_full_unstemmed Особенности применения синтетических аналогов гормонов щитовидной железы: результаты международного исследования 2020 THESIS* среди членов Белорусского общественного медицинского объединения «Эндокринология и метаболизм»
title_short Особенности применения синтетических аналогов гормонов щитовидной железы: результаты международного исследования 2020 THESIS* среди членов Белорусского общественного медицинского объединения «Эндокринология и метаболизм»
title_sort особенности применения синтетических аналогов гормонов щитовидной железы: результаты международного исследования 2020 thesis* среди членов белорусского общественного медицинского объединения «эндокринология и метаболизм»
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112860/
https://www.ncbi.nlm.nih.gov/pubmed/35262294
http://dx.doi.org/10.14341/probl12828
work_keys_str_mv AT šepelʹkevičap osobennostiprimeneniâsintetičeskihanalogovgormonovŝitovidnojželezyrezulʹtatymeždunarodnogoissledovaniâ2020thesissredičlenovbelorusskogoobŝestvennogomedicinskogoobʺedineniâéndokrinologiâimetabolizm
AT dydyškoûv osobennostiprimeneniâsintetičeskihanalogovgormonovŝitovidnojželezyrezulʹtatymeždunarodnogoissledovaniâ2020thesissredičlenovbelorusskogoobŝestvennogomedicinskogoobʺedineniâéndokrinologiâimetabolizm
AT ûrenâeb osobennostiprimeneniâsintetičeskihanalogovgormonovŝitovidnojželezyrezulʹtatymeždunarodnogoissledovaniâ2020thesissredičlenovbelorusskogoobŝestvennogomedicinskogoobʺedineniâéndokrinologiâimetabolizm
AT lobašovavl osobennostiprimeneniâsintetičeskihanalogovgormonovŝitovidnojželezyrezulʹtatymeždunarodnogoissledovaniâ2020thesissredičlenovbelorusskogoobŝestvennogomedicinskogoobʺedineniâéndokrinologiâimetabolizm
AT attanasior osobennostiprimeneniâsintetičeskihanalogovgormonovŝitovidnojželezyrezulʹtatymeždunarodnogoissledovaniâ2020thesissredičlenovbelorusskogoobŝestvennogomedicinskogoobʺedineniâéndokrinologiâimetabolizm
AT hegedûsl osobennostiprimeneniâsintetičeskihanalogovgormonovŝitovidnojželezyrezulʹtatymeždunarodnogoissledovaniâ2020thesissredičlenovbelorusskogoobŝestvennogomedicinskogoobʺedineniâéndokrinologiâimetabolizm
AT nadʹé osobennostiprimeneniâsintetičeskihanalogovgormonovŝitovidnojželezyrezulʹtatymeždunarodnogoissledovaniâ2020thesissredičlenovbelorusskogoobŝestvennogomedicinskogoobʺedineniâéndokrinologiâimetabolizm
AT negror osobennostiprimeneniâsintetičeskihanalogovgormonovŝitovidnojželezyrezulʹtatymeždunarodnogoissledovaniâ2020thesissredičlenovbelorusskogoobŝestvennogomedicinskogoobʺedineniâéndokrinologiâimetabolizm
AT papinié osobennostiprimeneniâsintetičeskihanalogovgormonovŝitovidnojželezyrezulʹtatymeždunarodnogoissledovaniâ2020thesissredičlenovbelorusskogoobŝestvennogomedicinskogoobʺedineniâéndokrinologiâimetabolizm
AT perrosp osobennostiprimeneniâsintetičeskihanalogovgormonovŝitovidnojželezyrezulʹtatymeždunarodnogoissledovaniâ2020thesissredičlenovbelorusskogoobŝestvennogomedicinskogoobʺedineniâéndokrinologiâimetabolizm